The Radiopharmaceutical Market growth continues to attract significant attention from investors, healthcare providers, and policymakers as the clinical and economic value of nuclear medicine becomes increasingly evident. The global healthcare landscape is undergoing profound transformation, with emphasis shifting from volume-based to value-based care models that reward improved patient outcomes...